Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Methods for treating diffuse large B-cell lymphoma and the use of biomarkers as a predictor of responsiveness to drugs

Methods for treating diffuse large B-cell lymphoma and the use of biomarkers as a predictor of responsiveness to drugs

US Patent 10689708 · Granted Jun 23, 2020

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Substituted 4-aminoisoindoline-1,3-dione compounds and second active agents for 2025
Methods of classifying diffuse large B-cell lymphoma2025
Methods and combinations for treatment and T cell modulation2025
Methods of treating hematological malignancies using 2-(2,6-dioxopiperidin-3-yl)2024
Methods of treating non-hodgkin lymphoma using 2-(2,6-dioxopiperidin-3-yl)-4-((22024
Combination therapy with 2-(4-chlorophenyl)-N-((2-(2,6-dioxopiperidin-3-yl)-1-ox2024
Methods of treating hematological malignancies using 2-(2,6-dioxopiperidin-3-yl)2023
Methods of treating chronic lymphocytic leukemia using 2-(2,6-dioxopiperidin-3-y2023
Treatment of a hematologic malignancy with 2-(4-chlorophenyl)-n-((2-(2,6-dioxopi2023
Substituted 4-aminoisoindoline-1,3-dione compounds and second active agents for 2023
Treatment of immune-related and inflammatory diseases2022
Methods of treating non-Hodgkin lymphoma using 2-(2,6-dioxopiperidin-3-yl)-4-((22022